another news portal
The review highlights nanocarriers, microspheres, hydrogels, microneedles, long-acting formulations, and co-formulations as promising but mostly early-stage strategies that still require stronger long-term clinical evidence.
A Nutrition Reviews supplement article reviewed controlled studies showing that culinary spice and herb blends may improve selected cardiometabolic risk markers, including post-meal triglycerides, insulin
Announcing a new publication for Acta Materia Medica journal. Vicatia thibetica de Boiss (V. thibetica), a traditional medicinal and edible plant used by the Bai
Your gut doesn’t just respond to your brain – it helps shape your emotions. Professor of Biomolecular Medicine Jon Swann explains why.
A therapy dog named Sage is helping children at Valley View Elementary outside Minneapolis cope with trauma from the immigration crackdown
Argentine scientists have identified a mechanism that allows pancreatic beta cells, which produce insulin, to become resistant to damage.
JMIR Publications today released a report on developments in the evidence gap in drug safety during pregnancy in its News and Perspectives section.
The true toll of long COVID may be double that of current estimates and hidden from current surveillance systems that rely on capturing diagnostic codes
This Cystic Fibrosis Awareness Month, Children’s Hospital Colorado (Children’s Colorado) is highlighting a growing shift in care: starting cystic fibrosis treatment before birth to improve
A study published in Nature by researchers at Duke University School of Medicine identifies a new way that G protein–coupled receptors (GPCRs) – targets of
More than a decade after removal of an adenoma-a precancerous mass-from the colon, alterations to the gut microbiome and metabolites remain and may drive heightened
Researchers at the Icahn School of Medicine at Mount Sinai have found evidence that people who fall at the extreme high or low ends of
KRAS is one of the oncogenes most frequently altered in cancer, mutated in approximately one-third of lung adenocarcinomas.
